Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.68 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.62 |
| ▸ | HDAC4 | P56524 | 6/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.52 |
| ▸ | HPGDS | O60760 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3089442 | 1.00 | HDAC6 (0.68) | HDAC6HDAC1HDAC4HDAC3HPGDS | |
| SCHEMBL3080077 | 0.88 | HDAC6 (0.64) | HDAC6HDAC1HDAC4HDAC3 | |
| SCHEMBL3080076 | 0.88 | HDAC6 (0.64) | HDAC6HDAC1HDAC4HDAC3 | |
| SCHEMBL6976440 | 0.84 | HDAC6 (0.70) | HDAC6HDAC1HDAC4HDAC3HPGDS | |
| SCHEMBL3094688 | 0.82 | HDAC6 (1.00) | HDAC6HDAC1HDAC4HDAC3HPGDS | |
| SCHEMBL28510300 | 0.79 | HSD17B1 (0.50) | HDAC6HDAC1HDAC4HDAC3NPSR1 | |
| SCHEMBL30584110 | 0.79 | HSD17B1 (0.50) | HDAC6HDAC1HDAC4HDAC3NPSR1 | |
| SCHEMBL3092930 | 0.79 | HDAC6 (0.49) | HDAC6HDAC1HDAC4HDAC3NPSR1 | |
| SCHEMBL3092917 | 0.79 | HDAC6 (0.49) | HDAC6HDAC1HDAC4HDAC3NPSR1 | |
| SCHEMBL2224563 | 0.77 | HDAC6 (1.00) | HDAC6HDAC1HDAC4HDAC3HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1987024-B1 | THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS | MSD ITALIA SRL (IT) | 2016-10-19 | — | — | EP | disclosed |
| US-7799825-B2 | Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2010-09-21 | — | — | US | disclosed |
| US-20090076101-A1 | Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors | MSD ITALIA S.R.L. (IT) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076101-A1 | Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors | HDAC1, HDAC4, HDAC7 | HDAC6 10/4885HDAC1 1/4885HDAC4 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.